Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 24, 2026

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening
06:50

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening

Published on: September 5, 2025

Exploiting metabolic differences in glioma therapy.

Francesca Galeffi1, Dennis A Turner

  • 1Neurosurgery, Duke University Medical Center, Durham, NC 27710, USA.

Current Drug Discovery Technologies
|February 21, 2012
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuous Accelerometry-Based Tremor Detection During Daily Living.

Sensors (Basel, Switzerland)·2026
Same author

Case Report: SPECT-CT-guided minimally invasive transverse process resection for Bertolotti syndrome.

Frontiers in surgery·2026
Same author

Mechanisms mediating dynamic changes in neural responses during deep brain stimulation.

Brain stimulation·2025
Same author

Effect of frequency on dual target deep brain stimulation.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2025
Same author

Dysregulated microvascular reactivity in hippocampus and cortex in CVN Alzheimer's disease mouse model.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2025
Same author

Study Protocol: Single-Blinded, Controlled, Clinical Trial Evaluating the Feasibility of Spinal Cord Stimulation for Improving Neuropathic Pain and Rehabilitation Outcomes in Patients With Thoracic Spinal Cord Injury.

Neurosurgery practice·2025

Brain cells, including astrocytes, have unique metabolic pathways. Astrocytoma cells exploit these differences, offering new therapeutic targets beyond traditional cancer treatments.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Oncology

Background:

  • Brain function relies on metabolic interactions between neurons and astrocytes.
  • Astrocytes support neurons through buffering, substrate provision, and synaptic transmission.
  • Neurons are highly oxidative and vulnerable to ischemia, unlike astrocytes which rely on glycolysis.

Purpose of the Study:

  • To explore metabolic differences between neurons, normal astrocytes, and astrocytoma cells.
  • To identify unique metabolic vulnerabilities in astrocytoma for targeted therapies.
  • To investigate how astrocytoma cells adapt astrocyte and general tumor metabolic mechanisms.

Main Methods:

  • Comparative analysis of metabolic pathways in different brain cell types.
  • Examination of enzyme and transporter differences.

Related Experiment Videos

Last Updated: May 24, 2026

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening
06:50

Advancements in the Metabolic Profiling of Three-Dimensional Brain Tumor Spheroids for Drug Screening

Published on: September 5, 2025

  • Investigation of hypoxia-inducible factor (HIF) regulation and glucose uptake mechanisms.

    • Main Results:

    • Astrocytoma cells exhibit high glycolytic rates, lactate extrusion, and proliferation under hypoxia.
    • Metabolic differences include variations in enzyme regulation, transporter sensitivities, and NADPH utilization for lipid synthesis.
    • Astrocytoma cells utilize mechanisms for enhanced metabolism, blood vessel generation, and suppression of cell death.

    Conclusions:

    • Metabolic distinctions between normal astrocytes and astrocytoma cells present therapeutic opportunities.
    • Targeting unique astrocytoma metabolic pathways can augment conventional cancer treatments.
    • These metabolic vulnerabilities are being explored in ongoing clinical trials for glioma treatment.